CNN health | Eli Lilly pauses trial of its monoclonal antibody to treat coronavirus

(CNN) – Drugmaker Eli Lilly said Tuesday it is pausing its trial of a combination antibody treatment for coronavirus for safety reasons.

Usually, clinical trials are paused because a volunteer has suffered a side effect or become ill, but the company did not say what happened.

“Safety is of the (utmost) importance to Lilly,” a spokesperson told CNN by email.

It said the trial’s Data Safety Monitoring Board (DSMB), an independent group of medical experts who monitor clinical trials, recommended the pause.  —read more—